Faulds D, Goa K, Benfield P. Cyclosporin A review of its pharmaco-dynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 1993 ; 45 : 953-1040.
Richardson C, Emery P. Clinical use of cyclosporin in rheumatoid arthritis. Drugs 1995 ; 50 (Suppl. 1) : 26-36.
Yocum D, Torley H. Cyclosporin in rheumatoid arthritis. Rheum Dis clin N Am 1995 ; 21 : 835-44.
van Rijthoven A, Dijkmans B, Goei The H, et al. Cyclosporin treatment for rheumatoid arthritis : A placebo controlled, double blind, multi-centre study. Ann Rheum Dis 1986 ; 45 : 726-31.
Dougados M, Awada H, Amor B. Cyclosporin in rheumatoid arthritis : A double blind placebo controlled study in 52 patients. Ann Rheum Dis 1988 ; 47 : 127-33.
Tugwell P, Bombardier C, Gent M, et al. Low dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990 ; 335 : 1051-5.
van Rijthoven A, Dijkmans B, Goei The H, et al. Comparaison of cyclosporin and D-penicillamine for rheumatoid arthritis : A randomized double blind multicentre study. J Rheumatatol 1991 ; 18 : 815-20.
Schattenkirchner M, Krüger K. Comparaison of cyclosporin A and azathioprine in the treatment of rheumatoid arthritis- Results of a double-blind multicentre study. Clin Rheumatol 1994 ; 13 : 248-55.
Landewé R, Goei The H , van Rijthoven A, et al. A randomized, double-blind, 24-week controlled study of low-dose cyclosporin versus chloroquine for early rheumatoid arthritis. Arthritis Rheum 1994 ; 37 : 637-43.
Førre O. Norvegian Arthritis Study Group radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporin. Arthritis Rheum 1994 ; 37 : 1506-12.
Tugwell P, Pincus T, Yocum D, et al. Combination therapy with cyclosporin and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995 ; 333 : 137-41.
Pasero G, Priolo F, Marubini E, et al. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis Rheum 1996 ; 39 : 1006-15.
Ferraccioli G, Bambara L, Ferraris M, et al. Effects of ciclosporin on joint damage in rheumatoid arthritis. Clin Exp Rheumatol 1997 ; 15 (Suppl. 17) : S83-S9.
Bendix G, Bjelle A. Adding low-dose cyclosporin A to parenteral gold therapy in rheumatoid arthritis : A double-blind placebo-controlled study. Br J Rheumatol 1996 ; 35 : 1142-9.
Tugwell P, Baker P. Guidelines for the use of cyclosporin in rheumatoid arthritis Clin Rheumatol 1995 ; 14 (Suppl. 2) : 37-41.
Noble S, Wagstaff A. Cyclosporin A review of its pharmacology and clinical potential in the treatment of systemic lupus erythematosus. Bio Drugs 1997 ; 7 : 483-501.
Manger K, Kalden J, Manger B. Cyclosporin A in the treatment of systemic lupus erythematosus : Results of an open clinical study. Br J Rheumatol 1996 ; 35 : 669-75.
Caccavo D, Lagan B, Mitterhofer A. Long-term treatment of systemic lupus erythematosus with cyclosporin A. Arthritis Rheum 1997 ; 40 : 27-35.
Pugh M, Collins N, Rai A. A case of adult dermatomyositis treated with CSA. (Letter to the editor). Br J Rheumatol 1992 ; 31 : 855-60.
Clements P, Lachenbruch P, Sterz M. et al. Cyclosporin in systemic sclerosis results of a forty-eigth-week open safety study in ten patients. Arthritis Rheum 1993 : 36 : 75-83.
Gisslinger H, Burghuber O, Stacher G, et al. Efficacy of cyclosporin A in systemic sclerosis. Clin Exp Rheumatol 1991 ; 9 : 383-90.
Zachariae H, Hansen H, Steen Olsen T. Hemolytic uremic syndrome in a patient with systemic sclerosis treated with cyclosporin A. Acta Derm Venereol 1992 ; 72 : 307-9.
Casoli P, Carretti C, Tumiati B. Case report scleroderma renal crisis as a possible complication of cyclosporin A Withdrawal. Clin Rheumatol 1994 ; 13 : 126-8.
Denton C, Sweny P, Abdulla A, et al. Acute renal failure occuring in scleroderma treated with cyclosporin A : A report of three cases. Br J Rheumatol 1994 ; 33 : 90-2.
